Relaxation With Virtual Reality on Fatigue and Comfort in Hemodialysis Patients

NCT05814679 | Completed

• 1 other identifier: E1-22-3047
• Study Type: interventional
• Target: 12
• Locations: 1 country
• Sites: 1

Brief Summary

Based on the task of providing the comfort of the patient, which is an indispensable part of the nursing profession, which many nurse theorists emphasize, there has been no study in the literature on the determination of the effect of virtual relaxation, which can be effective on the fatigue and comfort levels of patients receiving hemodialysis treatment. Therefore, the aim of this study is to examine the effect of virtual reality and relaxation on fatigue and comfort in hemodialysis patients.

Conditions

Chronic Kidney Diseases

Outcome Measures

Primary Outcomes (2)

• Fatigue Severity Scale

  In the study, fatigue symptom will be measured with the fatigue severity scale.

  Assessing change of fatigue severity scale scores baseline, after each application for three weeks. Between third and fifth weeks any intervention will not be implemented and fatigue severity scale score will measure fifth week.

• Hemodialysis Comfort Scale

  In the study, hemodialysis comfort will be measured with the hemodialysis comfort scale.

  Assessing change of fatigue comfort scale scores baseline, after each application for three weeks. Between third and fifth weeks any intervention will not be implemented and comfort scale score will measure fifth week.

Study Arms (2)

Intervention Group

EXPERIMENTAL

The patient will relax with virtual reality in the hemodialysis center with the researcher.

Other: Relaxation with virtual reality

Control Group

PLACEBO COMPARATOR

The patients in the control group will be given a training on the functions of the kidneys.

Other: Attention match

Interventions

Relaxation with virtual reality OTHER

In this research, a virtual reality relaxation video will be used in which the natural wonders are presented to the audience in an immersive environment.

Intervention Group

Attention match OTHER

kidney function instruction

Control Group

Eligibility Criteria

• Age: 18 Years - 65 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Receiving hemodialysis treatment for the last 6 months
• Receiving four-hour hemodialysis treatment three times a week
• years or older
• Deaf and visually impaired
• Without cognitive and psychiatric diagnosis
• Open to communication and cooperation
• Patients who agreed to participate in the study

You may not qualify if:

• Kidney transplant
• Discomfort due to virtual reality glasses
• Suspected/diagnosed COVID-19
• Patients who want to leave the study voluntarily
• Death

Sponsors & Collaborators

• Hacettepe University: lead

Study Sites (1)

Ankara Cit Hospital

Ankara, 06100, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Renal Insufficiency, Chronic

Condition Hierarchy (Ancestors)

Renal Insufficiency; Kidney Diseases; Urologic Diseases; Female Urogenital Diseases; Female Urogenital Diseases and Pregnancy Complications; Urogenital Diseases; Male Urogenital Diseases; Chronic Disease; Disease Attributes; Pathologic Processes; Pathological Conditions, Signs and Symptoms

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: DOUBLE
• Who Masked: PARTICIPANT, OUTCOMES ASSESSOR
• Purpose: SUPPORTIVE CARE
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Research Assistant (pHD)

Study Record Dates

• First Submitted: March 7, 2023
• First Posted: April 18, 2023
• Study Start: May 31, 2023
• Primary Completion: August 31, 2023
• Study Completion: August 31, 2023
• Last Updated: February 28, 2024

Record last verified: 2024-02

Data Sharing

• IPD Sharing: Will not share

Locations

TU (1)